Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer

BACKGROUND: The presence of circulating tumor cells (CTCs) in patients with breast cancer correlates to a bad prognosis. Yet, CTCs are detectable in only a minority of patients with progressive breast cancer, and factors that influence the abundance of CTCs remain elusive. METHODS: We conducted CTC...

Descripción completa

Detalles Bibliográficos
Autores principales: Vetter, Marcus, Landin, Julia, Szczerba, Barbara Maria, Castro-Giner, Francesc, Gkountela, Sofia, Donato, Cinzia, Krol, Ilona, Scherrer, Ramona, Balmelli, Catharina, Malinovska, Alexandra, Zippelius, Alfred, Kurzeder, Christian, Heinzelmann-Schwarz, Viola, Weber, Walter Paul, Rochlitz, Christoph, Aceto, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247738/
https://www.ncbi.nlm.nih.gov/pubmed/30458879
http://dx.doi.org/10.1186/s13058-018-1067-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247738/
https://www.ncbi.nlm.nih.gov/pubmed/30458879
http://dx.doi.org/10.1186/s13058-018-1067-y

Ejemplares similares